Table 7.
Agents | Susceptibility (%) | |||||
---|---|---|---|---|---|---|
A. schaalii (n = 1) |
C. glucuronolyticum (n = 5) |
F. hominis (n = 1) |
M. osloensis (n = 1) |
P. bettyae (n = 2) |
||
Pen | P | 20 | 100 | 100 | ||
AMP | 100 | 100 | 100 | |||
AMC | 100 | 100 | 100 | |||
Cef | CTX | 40 | 100 | |||
Carba | IMP | 100 | ||||
MEM | 0 | 100 | ||||
Quino | CIP | 40 | 100 | |||
LEV | 100 | |||||
MXF | 100 | |||||
Amg | CN | 60 | ||||
Gcp | VA | 100 | 100 | 100 | ||
Tetra | TE | 100 | 60 | |||
DO | 100 | |||||
Mcr | E | 0 | ||||
AZM | 100 | |||||
Linco | DA | 100 | 0 | 0 | ||
Oxa | LZD | 100 | ||||
Ntm | MTZ | 0 | 0 | |||
Rif | RD | 100 | ||||
Sulf | SXT | 100 | 100 | 100 |
* Antibiogram was not performed for G. vaginalis (n = 10). Penicillins (Pen), Cephalosporins (Cef), Carbapenems (Carba), Quinolones (Quino), Aminoglycosides (Amg), Glycopeptides (Gcp), Tetracycline (Tetra), Macrolides (Mcr), Lincosamides (Linco), Oxazolidone (Oxa), Nitroimidazole (Ntm), Rifampicin (Rif), Sulfamides (Sulf), Amoxicillin-Clavulanic (AMC), Ampicillin (AMP), Penicillin (P), Piperacillin-Tazobactam (TZP), Cefotaxime (CTX), Imipenem (IPM), Meropenem (MEM), Ciprofloxacin (CIP), Levofloxacin (LEV), Moxifloxacin (MXF), Gentamicin (CN), Vancomycin (VA), Tetracycline (TE), Doxycycline (DO), Erythromycin (E), Azithromycin (AZM), Clindamycin (DA), Linezolid (LZD), Metronidazole (MTZ), Rifampicin (RD), Trimethoprim-Sulfamethoxazole (SXT).